Advertisement

Advertisement

AU:CMB Stock Latest News

Cambium Bio Director Increases Stake Through Share Placement

Company AnnouncementsCambium Bio Director Increases Stake Through Share Placement

Cambium Bio Issues New Shares Under Cleansing Notice, Affirms Regulatory Compliance

PremiumCompany Announcements

Cambium Bio Issues New Shares Under Cleansing Notice, Affirms Regulatory Compliance

18d ago

Cambium Bio Seeks ASX Quotation for 4.36 Million New Shares

PremiumCompany Announcements

Cambium Bio Seeks ASX Quotation for 4.36 Million New Shares

18d ago

Cambium Bio Wins Strong Shareholder Backing for Capital-Raising Resolutions

PremiumCompany Announcements

Cambium Bio Wins Strong Shareholder Backing for Capital-Raising Resolutions

18d ago

Cambium Bio Narrows Half-Year Loss and Turns NTAs Positive as Revenue Grows

PremiumCompany Announcements

Cambium Bio Narrows Half-Year Loss and Turns NTAs Positive as Revenue Grows

1M ago

Cambium Bio Plans Significant Share Placement to Raise Equity

PremiumCompany AnnouncementsCambium Bio Plans Significant Share Placement to Raise Equity

2M ago

Cambium Bio Calls Vote on Share Placement to Boost Major Holder’s Control

Company Announcements

Cambium Bio Calls Vote on Share Placement to Boost Major Holder’s Control

2M ago

Cambium Bio Secures Funding and Advances Toward Phase 3 Trials for Elate Ocular

Company Announcements

Cambium Bio Secures Funding and Advances Toward Phase 3 Trials for Elate Ocular

2M ago

Cambium Bio Plans Share Placement to Raise Fresh Capital

PremiumCompany Announcements

Cambium Bio Plans Share Placement to Raise Fresh Capital

2M ago

Cambium Bio Raises A$2.4m at Premium from Major Shareholder to Fund Phase 3 Dry Eye Trials

PremiumCompany Announcements

Cambium Bio Raises A$2.4m at Premium from Major Shareholder to Fund Phase 3 Dry Eye Trials

2M ago

Cambium Bio Advances with Strategic Partnerships and R&D Incentives

PremiumCompany Announcements

Cambium Bio Advances with Strategic Partnerships and R&D Incentives

5M ago

Cambium Bio Corrects Director’s Interest Notice Date

PremiumCompany Announcements

Cambium Bio Corrects Director’s Interest Notice Date

5M ago

Regeneus Ltd. Director Increases Stake with New Share Acquisition

PremiumCompany AnnouncementsRegeneus Ltd. Director Increases Stake with New Share Acquisition

5M ago

Regeneus Director Increases Stake with New Share Acquisition

Company Announcements

Regeneus Director Increases Stake with New Share Acquisition

5M ago

Cambium Bio Limited Issues New Shares

Company Announcements

Cambium Bio Limited Issues New Shares

6M ago

Cambium Bio Limited Announces Quotation of New Securities

PremiumCompany Announcements

Cambium Bio Limited Announces Quotation of New Securities

6M ago

Cambium Bio Limited Reports AGM Results with Notable ‘First Strike’

PremiumCompany Announcements

Cambium Bio Limited Reports AGM Results with Notable ‘First Strike’

6M ago

Cambium Bio Limited Highlights Regenerative Medicine Advances at 2025 AGM

PremiumCompany Announcements

Cambium Bio Limited Highlights Regenerative Medicine Advances at 2025 AGM

6M ago

Cambium Bio Partners with Locus Cell for Global Production of Elate Ocular® ABI

PremiumCompany Announcements

Cambium Bio Partners with Locus Cell for Global Production of Elate Ocular® ABI

6M ago

Cambium Bio Limited Announces Proposed Securities Issue

PremiumCompany AnnouncementsCambium Bio Limited Announces Proposed Securities Issue

7M ago

Cambium Bio Limited Announces 2025 AGM Details

Company Announcements

Cambium Bio Limited Announces 2025 AGM Details

7M ago

Cambium Bio Partners with Benta SAS for Elate Ocular® Expansion

Company Announcements

Cambium Bio Partners with Benta SAS for Elate Ocular® Expansion

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >